MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Differential Effect of Dopaminergic Treatment on Bradykinesia Features and Limb-kinetic Apraxia in Parkinson’s Disease

    M. de Riggi, G. Paparella, A. Cannavacciuolo, D. Birreci, D. Costa, M. Passaretti, L. Angelini, M. Bologna (Rome, Italy)

    Objective: To investigate the differential effects of dopaminergic therapy on bradykinesia and limb-kinetic apraxia in PD patients using kinematic analysis. Additionally, transcranial magnetic stimulation (TMS)…
  • 2025 International Congress

    Decoding Parkinson’s Progression: Longitudinal Volumetric MRI Biomarkers in Prodromal and Clinical Stages

    S. Datta, M. Acharya, N. Ghosh, B. Chakraborty (Kharagpur, India)

    Objective: This study investigates MRI volumetric analysis via VBM as a biomarker for early PD detection, focusing on structural alterations in deep gray matter regions…
  • 2025 International Congress

    Boosting the LTP-like Plasticity Effect of Intermittent Theta-burst Stimulation with Gamma Transcranial Alternating Current Stimulation improves Bradykinesia in Parkinson’s Disease

    G. Paparella, D. Costa, M. de Riggi, L. Angelini, A. Cannavacciuolo, S. Pietracupa, A. Berardelli, A. Guerra, M. Bologna (Pozzilli

    Objective: We  investigated whether transcranial alternating current stimulation (tACS) applied at the gamma frequency (γ) frequency on the primary motor cortex (M1) improves long-term potentiation…
  • 2025 International Congress

    Semi-quantitative Evaluation of Midbrain Accumulation in 123I-FP-CIT SPECT in Parkinson’s disease and Parkinsonian Syndromes

    T. Totsune, T. Baba, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)

    Objective: To establish a method for evaluating midbrain accumulation of 123I-FP-CIT SPECT and assess its ability to differentiate between Parkinson’s disease (PD) and Parkinsonian syndromes…
  • 2025 International Congress

    Cerebral Glucose Metabolic Features of GBA-Parkinson’s Disease as a window into cognitive impairment

    P. Mitrotti, R. Calabrese, M. Picascia, L. Gallo, R. Malito, A. Panzacchi, C. Galandra, M. Todisco, R. Zangaglia, D. Perani, A. Chiti, EM. Valente, C. Tassorelli, S. Camminiti, M. Avenali (Pavia, Italy)

    Objective: to investigate cerebral glucose metabolism via fluorodeoxyglucose positron emission tomography (FDG-PET) and its correlation to clinical features in Parkinson’s disease (PD) patients with GBA1…
  • 2025 International Congress

    Novel Parkinson’s Disease Genetic Risk Factors Within and Across European Populations

    GP2. Parkinson'S_genetics_program (Bethesda, USA)

    Objective: To assess genome-wide genetic risk for Parkinson’s disease (PD) within and across genetically determined European ancestries (European, Ashkenazi Jewish, Finnish, and Icelandic). We conducted…
  • 2025 International Congress

    Hispanic Recruitment to PD GENEration at Columbia University

    A. Arroyo, H. Lee, M. Dini, L. Caboy, K. Ghosh Galvelis, R. de Leon, J. Agin-Liebes (New York, USA)

    Objective: To evaluate the effect of having a Hispanic, Spanish-speaking research coordinator on recruitment of Hispanic and Latinx people with Parkinson's disease to the PD…
  • 2025 International Congress

    A unique genetic duality: GAK and SCN4A Mutations in Myasthenic Syndrome and Early-Onset Parkinsonism in a Peruvian woman: A Case Report

    W. Trillo Alvarez, A. Carpio Peña, L. Delgado Villanueva, A. Gomez Azcue, H. Paz-Soldan Candia, M. Nieto Rosas, D. Flores Barragan, F. Arismendi Gomez (AREQUIPA, Peru)

    Objective: To present the first genetically characterized non-linear summative damage characterized case resulting in early-onset parkinsonism associated with congenital myasthenia Background: The GAK (Cyclin G…
  • 2025 International Congress

    Gene-Caffeine Interaction in Parkinson’s Disease: A Case-Control Study of Alpha-synuclein SNPs

    BG. Yan, E. Ng, Y. Zhao, EK. Tan (Singapore, Singapore)

    Objective: Investigating the interaction between genetic susceptibility and caffeine intake in modulating Parkinson’s disease (PD) risk. Background: PD arises from a complex interplay of genetic…
  • 2025 International Congress

    Oculomotor Differences in PARK2 PD: a Study of Structured and Unstructured Eye Movements in an Irish Genetic Cohort

    A. Gallagher, C. O'Keeffe, J. Inocentes, M. Bradley, E. Donlon, B. Coe, B. White, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin, Ireland)

    Objective: To identify and measure how eye movements differ between biallelic PARK2 carriers, carriers of a single PARK2 variant and non-carriers using structured and unstructured…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley